Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in leukemia (original) (raw)

• Pui, C.H. et al. Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region. Lancet 359, 1909–1915 (2002).
  Article Google Scholar
• Liu, H., Cheng, E.H. & Hsieh, J.J. MLL fusions: pathways to leukemia. Cancer Biol. Ther. 8, 1204–1211 (2009).
  Article CAS Google Scholar
• Sorensen, P.H. et al. Molecular rearrangements of the MLL gene are present in most cases of infant acute myeloid leukemia and are strongly correlated with monocytic or myelomonocytic phenotypes. J. Clin. Invest. 93, 429–437 (1994).
  Article CAS Google Scholar
• Cox, M.C. et al. Chromosomal aberration of the 11q23 locus in acute leukemia and frequency of MLL gene translocation: results in 378 adult patients. Am. J. Clin. Pathol. 122, 298–306 (2004).
  Article CAS Google Scholar
• Hess, J.L. MLL: a histone methyltransferase disrupted in leukemia. Trends Mol. Med. 10, 500–507 (2004).
  Article CAS Google Scholar
• Popovic, R. & Zeleznik-Le, N.J. MLL: how complex does it get? J. Cell. Biochem. 95, 234–242 (2005).
  Article CAS Google Scholar
• Krivtsov, A.V. & Armstrong, S.A. MLL translocations, histone modifications and leukaemia stem-cell development. Nat. Rev. Cancer 7, 823–833 (2007).
  Article CAS Google Scholar
• Slany, R.K. The molecular biology of mixed lineage leukemia. Haematologica 94, 984–993 (2009).
  Article CAS Google Scholar
• Hess, J.L., Yu, B.D., Li, B., Hanson, R. & Korsmeyer, S.J. Defects in yolk sac hematopoiesis in Mll-null embryos. Blood 90, 1799–1806 (1997).
  CAS PubMed Google Scholar
• Lawrence, H.J. et al. Mice bearing a targeted interruption of the homeobox gene HOXA9 have defects in myeloid, erythroid and lymphoid hematopoiesis. Blood 89, 1922–1930 (1997).
  CAS PubMed Google Scholar
• Rozovskaia, T. et al. Upregulation of Meis1 and HoxA9 in acute lymphocytic leukemias with the t(4: 11) abnormality. Oncogene 20, 874–878 (2001).
  Article CAS Google Scholar
• Ayton, P.M. & Cleary, M.L. Transformation of myeloid progenitors by MLL oncoproteins is dependent on Hoxa7 and Hoxa9. Genes Dev. 17, 2298–2307 (2003).
  Article CAS Google Scholar
• Zeisig, B.B. et al. Hoxa9 and Meis1 are key targets for MLL-ENL–mediated cellular immortalization. Mol. Cell. Biol. 24, 617–628 (2004).
  Article CAS Google Scholar
• Wong, P., Iwasaki, M., Somervaille, T.C., So, C.W. & Cleary, M.L. Meis1 is an essential and rate-limiting regulator of MLL leukemia stem cell potential. Genes Dev. 21, 2762–2774 (2007); erratum 21, 3017 (2007).
  Article CAS Google Scholar
• Argiropoulos, B. & Humphries, R.K. Hox genes in hematopoiesis and leukemogenesis. Oncogene 26, 6766–6776 (2007).
  Article CAS Google Scholar
• Rice, K.L. & Licht, J.D. HOX deregulation in acute myeloid leukemia. J. Clin. Invest. 117, 865–868 (2007).
  Article CAS Google Scholar
• Ernst, P., Wang, J. & Korsmeyer, S.J. The role of MLL in hematopoiesis and leukemia. Curr. Opin. Hematol. 9, 282–287 (2002).
  Article Google Scholar
• Slany, R.K. When epigenetics kills: MLL fusion proteins in leukemia. Hematol. Oncol. 23, 1–9 (2005).
  Article CAS Google Scholar
• Yokoyama, A. et al. The menin tumor suppressor protein is an essential oncogenic cofactor for MLL-associated leukemogenesis. Cell 123, 207–218 (2005).
  Article CAS Google Scholar
• Caslini, C. et al. Interaction of MLL amino terminal sequences with menin is required for transformation. Cancer Res. 67, 7275–7283 (2007).
  Article CAS Google Scholar
• Chen, Y.X. et al. The tumor suppressor menin regulates hematopoiesis and myeloid transformation by influencing Hox gene expression. Proc. Natl. Acad. Sci. USA 103, 1018–1023 (2006).
  Article CAS Google Scholar
• Chandrasekharappa, S.C. et al. Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 276, 404–407 (1997).
  Article CAS Google Scholar
• Marx, S.J. Molecular genetics of multiple endocrine neoplasia types 1 and 2. Nat. Rev. Cancer 5, 367–375 (2005).
  Article CAS Google Scholar
• Hughes, C.M. et al. Menin associates with a trithorax family histone methyltransferase complex and with the hoxc8 locus. Mol. Cell 13, 587–597 (2004).
  Article CAS Google Scholar
• Yokoyama, A. et al. Leukemia proto-oncoprotein MLL forms a SET1-like histone methyltransferase complex with menin to regulate Hox gene expression. Mol. Cell. Biol. 24, 5639–5649 (2004).
  Article CAS Google Scholar
• Grembecka, J., Belcher, A.M., Hartley, T. & Cierpicki, T. Molecular basis of the mixed lineage leukemia-menin interaction: implications for targeting mixed lineage leukemias. J. Biol. Chem. 285, 40690–40698 (2010).
  Article CAS Google Scholar
• Mayer, M. & Meyer, B. Group epitope mapping by saturation transfer difference NMR to identify segments of a ligand in direct contact with a protein receptor. J. Am. Chem. Soc. 123, 6108–6117 (2001).
  Article CAS Google Scholar
• Murai, M.J., Chruszcz, M., Reddy, G., Grembecka, J. & Cierpicki, T. Crystal structure of menin reveals binding site for mixed lineage leukemia (MLL) protein. J. Biol. Chem. 286, 31742–31748 (2011).
  Article CAS Google Scholar
• Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65, 55–63 (1983).
  Article CAS Google Scholar
• Lavau, C., Szilvassy, S.J., Slany, R. & Cleary, M.L. Immortalization and leukemic transformation of a myelomonocytic precursor by retrovirally transduced HRX-ENL. EMBO J. 16, 4226–4237 (1997).
  Article CAS Google Scholar
• Thiel, A.T. et al. MLL-AF9–induced leukemogenesis requires coexpression of the wild-type Mll allele. Cancer Cell 17, 148–159 (2010).
  Article CAS Google Scholar
• Drabkin, H.A. et al. Quantitative HOX expression in chromosomally defined subsets of acute myelogenous leukemia. Leukemia 16, 186–195 (2002).
  Article CAS Google Scholar
• Yokoyama, A., Lin, M., Naresh, A., Kitabayashi, I. & Cleary, M.L. A higher-order complex containing AF4 and ENL family proteins with P-TEFb facilitates oncogenic and physiologic MLL-dependent transcription. Cancer Cell 17, 198–212 (2010).
  Article CAS Google Scholar
• Thompson, A. et al. Global down-regulation of HOX gene expression in PML-RARα+ acute promyelocytic leukemia identified by small-array real-time PCR. Blood 101, 1558–1565 (2003).
  Article CAS Google Scholar
• Fiskus, W. et al. Histone deacetylase inhibitors deplete enhancer of zeste 2 and associated polycomb repressive complex 2 proteins in human acute leukemia cells. Mol. Cancer Ther. 5, 3096–3104 (2006).
  Article CAS Google Scholar
• Golub, T.R. et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 286, 531–537 (1999).
  Article CAS Google Scholar
• Quentmeier, H. et al. Expression of HOX genes in acute leukemia cell lines with and without MLL translocations. Leuk. Lymphoma 45, 567–574 (2004).
  Article CAS Google Scholar
• Thomas, M. et al. Targeting MLL-AF4 with short interfering RNAs inhibits clonogenicity and engraftment of t(4;11)-positive human leukemic cells. Blood 106, 3559–3566 (2005).
  Article CAS Google Scholar
• Armstrong, S.A. et al. MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia. Nat. Genet. 30, 41–47 (2002).
  Article CAS Google Scholar
• Milne, T.A. et al. Menin and MLL cooperatively regulate expression of cyclin-dependent kinase inhibitors. Proc. Natl. Acad. Sci. USA 102, 749–754 (2005).
  Article CAS Google Scholar
• Muntean, A.G. et al. The PAF complex synergizes with MLL fusion proteins at HOX loci to promote leukemogenesis. Cancer Cell 17, 609–621 (2010).
  Article CAS Google Scholar
• Milne, T.A. et al. MLL associates specifically with a subset of transcriptionally active target genes. Proc. Natl. Acad. Sci. USA 102, 14765–14770 (2005).
  Article CAS Google Scholar